Skip to main content

Find Clinical Trials

Home
Conditions
Mesothelioma, Malignant

Clinical trial condition

Mesothelioma, Malignant

Explore clinical trials studying Mesothelioma, Malignant. Study availability and eligibility vary by location and protocol.

225 public trials 44 recruiting studies

Refine in advanced search Browse all conditions

Mesothelioma, Malignant trial results

Not Yet Recruiting

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

NCT06416930

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition

NCT05425576

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

NCT05698238

Conditions: Adenoma, Breast Diseases, Breast Neoplasms, +25 more
Locations: Not specified

View Trial Details

Completed

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

NCT05278975

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +18 more
Locations: South Mead North Bristol Hopsital Bristol, United Kingdom

Leeds Teaching Hospital Leeds, United Kingdom

Northumbria NorthTyne Side General Hospital North Shields, United Kingdom

NHS Greater Glasgow & Clyde Glasgow, United Kingdom

View Trial Details

Completed

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

NCT02959463

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pembrolizumab in Treating Patients With Malignant Mesothelioma

NCT02399371

Conditions: Adenoma, Biphasic Mesothelioma, Epithelioid Mesothelioma, +26 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

NCT03710876

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: University of California, Los Angeles (UCLA) - Medical Center Los Angeles, California, United States

University of California, San Francisco (UCSF) San Francisco, California, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Marlene & Stewart Greenbaum Comprehensive Cancer Center Baltimore, Maryland, United States

View all 29 locations

View Trial Details

Completed

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

NCT03678350

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Short Neoadjuvant Hemithoracic IMRT for MPM

NCT00797719

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

From Presentation to Diagnosis: Patterns of Pleural Effusion

NCT07449624

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +14 more
Locations: Mohamed AbdElmoniem Al Mansurah, Egypt

View Trial Details